Panel Recommends Warnings for Ritalin and Other Stimulants[ ... Read the full article ... ]
By THE ASSOCIATED PRESS
Published: February 9, 2006
Filed at 4:13 p.m. ET
WASHINGTON (AP) -- Federal science advisers voted narrowly Thursday to recommend the most serious type of warning labels for Ritalin and other stimulants that are used to treat attention deficit hyperactivity disorder.
The 8-7 vote, with one abstention, by the Food and Drug Administration committee was to recommend adding ''black box'' safety warnings to ADHD drugs. Doctors prescribe the increasingly popular drugs to about 2 million children and 1 million adults a month.
The FDA isn't required to follow the recommendations of its advisory committees but typically does.
Anthony H. Risser | neuroscience | neuropsychology | brain